• LAST PRICE
    46.9050
  • TODAY'S CHANGE (%)
    Trending Down-0.4150 (-0.8770%)
  • Bid / Lots
    46.8700/ 10
  • Ask / Lots
    46.9400/ 2
  • Open / Previous Close
    46.9400 / 47.3200
  • Day Range
    Low 46.4400
    High 47.6900
  • 52 Week Range
    Low 37.5500
    High 91.1000
  • Volume
    526,584
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 47.32
TimeVolumeCRSP
09:32 ET3500946.78
09:34 ET1093246.96
09:36 ET907347.115
09:38 ET399247.28
09:39 ET438047.305
09:41 ET379247.55
09:43 ET185547.39
09:45 ET155047.385
09:48 ET505447.46
09:50 ET750647.6587
09:52 ET439747.6453
09:54 ET162847.585
09:56 ET110047.48
09:57 ET275547.38
09:59 ET395347.32
10:01 ET283147.33
10:03 ET286647.33
10:06 ET137547.35
10:08 ET620347.32
10:10 ET124147.225
10:12 ET187547.2
10:14 ET183347.06
10:15 ET122947.0961
10:17 ET195047.06
10:19 ET536747.075
10:21 ET911247.05
10:24 ET150047.08
10:26 ET170047.09
10:28 ET165647.085
10:30 ET204247.055
10:32 ET50047.04
10:33 ET673047.17
10:35 ET422347.25
10:37 ET73347.34
10:39 ET52047.255
10:42 ET77547.24
10:44 ET344247.243
10:46 ET70047.22
10:48 ET673847.2
10:50 ET225547.2
10:51 ET103147.2
10:53 ET958547.2
10:55 ET230947.195
10:57 ET171047.13
11:00 ET89647.11
11:02 ET172447.115
11:04 ET70047.17
11:06 ET72947.2
11:08 ET270047.19
11:09 ET1193847.1
11:11 ET300847.07
11:13 ET687947.185
11:15 ET70047.275
11:18 ET142647.29
11:20 ET52547.3245
11:22 ET95047.24
11:24 ET60047.285
11:26 ET41847.31
11:27 ET709647.17
11:29 ET2119647.16
11:31 ET190047.13
11:33 ET233547.05
11:36 ET870746.96
11:38 ET905246.94
11:40 ET903746.87
11:42 ET481046.75
11:44 ET266046.79
11:45 ET925746.825
11:47 ET966846.89
11:49 ET280046.94
11:51 ET174047.02
11:54 ET183347
11:56 ET84146.95
11:58 ET133347
12:00 ET503246.96
12:02 ET77346.98
12:03 ET167746.98
12:05 ET378446.88
12:07 ET240046.85
12:09 ET91046.88
12:12 ET40046.95
12:14 ET76546.94
12:16 ET41346.93
12:18 ET60646.96
12:20 ET122647.01
12:21 ET110646.94
12:23 ET153647.05
12:25 ET360047.0583
12:27 ET48447.055
12:30 ET162447.135
12:32 ET146647.18
12:34 ET23847.23
12:36 ET623047.195
12:38 ET402247.2001
12:39 ET251747.23
12:41 ET104847.15
12:43 ET70047.07
12:45 ET10047.11
12:48 ET30047.17
12:50 ET70547.14
12:52 ET23447.11
12:54 ET10047.1
12:56 ET31147.06
12:59 ET171047.14
01:01 ET280047.04
01:03 ET93646.9895
01:06 ET102547.0191
01:08 ET52947.08
01:10 ET30047.0353
01:12 ET20647.03
01:14 ET124447
01:15 ET10046.9601
01:17 ET166447.02
01:19 ET32047.02
01:21 ET126547.03
01:24 ET100047.07
01:26 ET45047.08
01:28 ET25447.08
01:30 ET50047.01
01:32 ET67346.98
01:33 ET147046.96
01:35 ET59846.9821
01:37 ET192447.02
01:39 ET81347
01:42 ET52546.9754
01:44 ET160046.97
01:46 ET163747.01
01:48 ET320046.9998
01:50 ET170047.01
01:51 ET43047
01:53 ET180047
01:57 ET254047.0648
02:00 ET109047.135
02:02 ET585047.18
02:04 ET72447.11
02:06 ET141047.1231
02:08 ET160847
02:09 ET60047.0738
02:11 ET160047.125
02:13 ET163946.905
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRSP
CRISPR Therapeutics AG
4.2B
-14.6x
---
United StatesDNLI
Denali Therapeutics Inc
4.4B
-10.0x
---
United StatesAPLS
Apellis Pharmaceuticals Inc
4.6B
-10.4x
---
United StatesADMA
ADMA Biologics Inc
4.2B
140.6x
---
United StatesFOLD
Amicus Therapeutics Inc
3.4B
-26.9x
---
United StatesAXSM
Axsome Therapeutics Inc
4.5B
-13.7x
---
As of 2024-09-30

Company Information

CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Contact Information

Headquarters
Baarerstrasse 14ZUG, ZUG, Switzerland 6300
Phone
---
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Samarth Kulkarni
Chief Financial Officer
Raju Prasad
Chief Operating Officer
Julianne Bruno
General Counsel, Secretary
James Kasinger
Chief Medical Officer
Naimish Patel

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.2B
Revenue (TTM)
$202.2M
Shares Outstanding
85.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.67
EPS
$-3.21
Book Value
$23.52
P/E Ratio
-14.6x
Price/Sales (TTM)
20.6
Price/Cash Flow (TTM)
---
Operating Margin
-175.38%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.